Item Details

Print View

Levodopa-Induced Dyskinesia in Parkinson's Disease

Susan H. Fox, Jonathan M. Brotchie, editors
Format
EBook; Book; Online
Published
London : Springer, 2014.
Language
English
ISBN
9781447165033, 1447165039, 9781447165026
Access Restriction
Electronic access is available for UVA students, faculty, staff, and affiliates only. IP address verification required.
Contents
  • Phenomenology of Levodopa-Induced Dyskinesia
  • Dyskinesia Rating Scales in Parkinson's Disease
  • Epidemiology of Levodopa-Induced Dyskinesia
  • Risk Factors for Levodopa-Induced Dyskinesia
  • Pharmacological Treatment Options for Levodopa-Induced Dyskinesia
  • Surgical Options for Levodopa-Induced Dyskinesia in Parkinson?s Disease
  • Basal Ganglia Circuitry Models of L-DOPA-Induced Dyskinesia
  • Pharmacological Properties of Levodopa
  • Dopamine Receptors and LID
  • The Serotonergic System In Levodopa-Induced Dyskinesia
  • The Opioid System in Levodopa-Induced Dyskinesia
  • Glutamate Receptors and Levodopa-Induced Dyskinesia
  • Cannabinoids and Levodopa-Induced Dyskinesia
  • The Role of the Noradrenergic System and its Receptors In Levodopa-Induced Dyskinesia
  • Involvement of the Cholinergic System in Levodopa-Induced Dyskinesia
  • New Clinical Trials for Levodopa-Induced Dyskinesia
  • Preclinical Models of Levodopa-Induced Dyskinesia
  • Final Thoughts: Summary and Future Therapeutic Strategies in LID.
Description
1 online resource (xii, 368 pages) : illustrations
Notes
HEALTH SCIENCES: RITTENHOUSE APPROVAL INV. 4512659, CONRAD, #15087335, FY14-15, $...
Copyright Not EvaluatedCopyright Not Evaluated
Technical Details
  • Access in Virgo Classic
  • Staff View

    LEADER 02968cam a2200517Ii 4500
    001 u6439865
    003 SIRSI
    005 20141209090911.0
    006 m o d
    007 cr cnu---unuuu
    008 141020s2014 enka ob 001 0 eng d
    020
      
      
    a| 9781447165033 q| electronic bk.
    020
      
      
    a| 1447165039 q| electronic bk.
    020
      
      
    z| 9781447165026
    035
      
      
    a| (OCoLC)893426429
    049
      
      
    a| VAMM n| [Electronic Book/SPGR]
    040
      
      
    a| N$T b| eng e| rda e| pn c| N$T d| GW5XE d| E7B d| YDXCP
    050
      
    4
    a| RC382 b| .L48 2014
    072
      
    7
    a| HEA x| 039000 2| bisacsh
    072
      
    7
    a| MED x| 014000 2| bisacsh
    072
      
    7
    a| MED x| 022000 2| bisacsh
    072
      
    7
    a| MED x| 112000 2| bisacsh
    072
      
    7
    a| MED x| 045000 2| bisacsh
    082
    0
    4
    a| 616.8/33 2| 23
    245
    0
    0
    a| Levodopa-induced dyskinesia in Parkinson's disease / c| Susan H. Fox, Jonathan M. Brotchie, editors.
    264
      
    1
    a| London : b| Springer, c| 2014.
    300
      
      
    a| 1 online resource (xii, 368 pages) : b| illustrations
    336
      
      
    a| text b| txt 2| rdacontent
    337
      
      
    a| computer b| c 2| rdamedia
    338
      
      
    a| online resource b| cr 2| rdacarrier
    504
      
      
    a| HEALTH SCIENCES: RITTENHOUSE APPROVAL INV. 4512659, CONRAD, #15087335, FY14-15, $...
    505
    0
      
    a| Phenomenology of Levodopa-Induced Dyskinesia -- Dyskinesia Rating Scales in Parkinson's Disease -- Epidemiology of Levodopa-Induced Dyskinesia -- Risk Factors for Levodopa-Induced Dyskinesia -- Pharmacological Treatment Options for Levodopa-Induced Dyskinesia -- Surgical Options for Levodopa-Induced Dyskinesia in Parkinson?s Disease -- Basal Ganglia Circuitry Models of L-DOPA-Induced Dyskinesia -- Basal Ganglia Circuitry Models of L-DOPA-Induced Dyskinesia -- Pharmacological Properties of Levodopa -- Dopamine Receptors and LID -- The Serotonergic System In Levodopa-Induced Dyskinesia -- The Opioid System in Levodopa-Induced Dyskinesia -- Glutamate Receptors and Levodopa-Induced Dyskinesia -- Cannabinoids and Levodopa-Induced Dyskinesia -- The Role of the Noradrenergic System and its Receptors In Levodopa-Induced Dyskinesia -- Involvement of the Cholinergic System in Levodopa-Induced Dyskinesia -- New Clinical Trials for Levodopa-Induced Dyskinesia -- Preclinical Models of Levodopa-Induced Dyskinesia -- Final Thoughts: Summary and Future Therapeutic Strategies in LID.
    506
      
      
    a| Electronic access is available for UVA students, faculty, staff, and affiliates only. IP address verification required.
    650
      
    0
    a| Parkinson's disease.
    650
      
    0
    a| Movement disorders.
    655
      
    7
    a| Electronic books 2| local
    700
    1
      
    a| Fox, Susan H. e| editor.
    700
    1
      
    a| Brotchie, Jonathan M., e| editor.
    856
    4
    0
    u| http://proxy01.its.virginia.edu/login?url=http://dx.doi.org/10.1007/978-1-4471-6503-3
    994
      
      
    a| 92 b| VAM
    596
      
      
    a| 19
    999
      
      
    a| RC382 .L48 2014 ELECTRONIC w| HS-LC i| 6439865-1001 l| INTERNET m| HEALTHSCI t| E-BOOK
▾See more
▴See less

Availability

Google Preview

Google Books Preview

Read Online